SPY303.53+4.45 1.49%
DIA255.77+5.52 2.21%
IXIC9,412.36+72.14 0.77%

SVB Leerink Maintains Outperform on Pacira BioSciences, Raises Price Target to $45

SVB Leerink maintains Pacira BioSciences (NASDAQ:PCRX) with a Outperform and raises the price target from $44 to $45.

Benzinga · 05/08/2020 10:31

SVB Leerink maintains Pacira BioSciences (NASDAQ:PCRX) with a Outperform and raises the price target from $44 to $45.